SUBSCRIBE TODAY AND SAVE 50%

Drug Industry Daily is the only electronic briefing that delivers coverage of developments at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry around the world.

Each issue highlights the top issues affecting the industry including:

  • Patent exclusivity
  • Market globalization enforcement
  • EU pharmacovigilance
  • New inspection trends
  • Advertising practices
  • CAPA warning letters
  • Recalls
  • Drug Approvals
  • And more

Plus in every issue, subscribers receive the additional benefit of links to exclusive documents that support each article, such as draft and final guidances, 483s and warning letters, proposed rules, closeout letters, full text of proposed legislation and GAO reports.

 

Daily, 250 issues/year, Electronic delivery.

 

$1,695 $847

 
 

Key Benefits

LINKS TO KEY DOCUMENTS — You get links to key documents that support DID's articles such as draft and final guidances, 483s and warning letters, proposed rules, closeout letter, full text of proposed legislation and GAO reports.

ONLINE ACCESS — Consider Drug Industry Daily  your personal library! Search your current issue — and hundreds of past issues — by keyword and relevancy.

DAILY FEATURES SECTION — Each day of the week covers a different topic with a recap of the week on Friday. 

  • Monday — Regulatory Update
  • Tuesday — People on the Move
  • Wednesday — Legislative Update
  • Thursday — FDA Meeting Planner
  • Friday — Week In Review